These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1733580)
1. Monitoring cyclosporine in liver-transplant recipients: effects of clinical status on the performance of two monoclonal antibody-based methods. Tredger JM; Gonde CE; Williams R Clin Chem; 1992 Jan; 38(1):108-13. PubMed ID: 1733580 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation. Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K Clin Chem; 1992 Jan; 38(1):123-6. PubMed ID: 1733584 [TBL] [Abstract][Full Text] [Related]
3. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients. McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128 [TBL] [Abstract][Full Text] [Related]
5. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay. Armijo JA; Navarro FA; Angeles de Cos M Ther Drug Monit; 1992 Aug; 14(4):333-8. PubMed ID: 1519309 [TBL] [Abstract][Full Text] [Related]
6. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients. Taylor PJ; Salm P; Norris RL; Ravenscroft PJ; Pond SM Ther Drug Monit; 1994 Oct; 16(5):526-30. PubMed ID: 7846754 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay. Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649 [TBL] [Abstract][Full Text] [Related]
8. Cholestasis in transplant patients--what is the role of cyclosporin? Bluhm RE; Rodgers WH; Black DL; Wilkinson GR; Branch R Aliment Pharmacol Ther; 1992 Apr; 6(2):207-19. PubMed ID: 1600041 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cyclosporine blood levels measured by radioimmunoassay and TDx assay using monoclonal antibodies. Klotz U Ther Drug Monit; 1991 Sep; 13(5):461-3. PubMed ID: 1957340 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine concentrations in blood after liver transplantation: correlation of immunoassay results with clinical events. Haven MC; Sobeski LM; Earl RA; Markin RS Clin Chem; 1989 Apr; 35(4):564-8. PubMed ID: 2649273 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of instrumental, nonisotopic immunoassays (fluorescence polarization immunoassay and enzyme-multiplied immunoassay technique) for cyclosporine monitoring in whole blood after kidney and liver transplantation. Beutler D; Molteni S; Zeugin T; Thormann W Ther Drug Monit; 1992 Oct; 14(5):424-32. PubMed ID: 1448852 [TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC. Annesley TM; Coombs RC; Orsulak PJ Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536 [TBL] [Abstract][Full Text] [Related]
13. Relative performance of specific and nonspecific fluorescence polarization immunoassay for cyclosporine in transplant patients. Chan GL; Weinstein SS; LeFor WW; Spoto E; Kahana L; Shires DL Ther Drug Monit; 1992 Feb; 14(1):42-7. PubMed ID: 1546388 [TBL] [Abstract][Full Text] [Related]
14. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites. Lensmeyer GL; Wiebe DA; Carlson IH; deVos DJ Clin Chem; 1990 Jan; 36(1):119-23. PubMed ID: 2297901 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients. Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710 [TBL] [Abstract][Full Text] [Related]
16. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation. Stephens E; Bolderson I; Clark B; Kinsey S; Gooi HC; Cook G Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881 [TBL] [Abstract][Full Text] [Related]
17. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy. Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine pharmacokinetics in pediatric liver transplant recipients: utility of the monoclonal radioimmunoassay single point blood concentration. Dunn SP; Cooney GF; Kulinsky AV; Falkenstein K; Kaiser B; Goldsmith B Transplant Proc; 1994 Feb; 26(1):151. PubMed ID: 8108916 [No Abstract] [Full Text] [Related]